terazosin

Generic: terazosin hydrochloride

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler bryant ranch prepack
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 10 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 63629-5237
Product ID 63629-5237_1b04f70e-e8d8-4005-82f5-53b9cf3c4e99
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2004-12-20

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 636295237
Hyphenated Format 63629-5237

Supplemental Identifiers

RxCUI
260376 313217
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (63629-5237-1)
  • 28 CAPSULE in 1 BOTTLE (63629-5237-2)
  • 90 CAPSULE in 1 BOTTLE (63629-5237-3)
source: ndc

Packages (3)

63629-5237-1 30 CAPSULE in 1 BOTTLE (63629-5237-1) 63629-5237-2 28 CAPSULE in 1 BOTTLE (63629-5237-2) 63629-5237-3 90 CAPSULE in 1 BOTTLE (63629-5237-3)

Ingredients (1)

terazosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1b04f70e-e8d8-4005-82f5-53b9cf3c4e99", "openfda": {"unii": ["D32S14F082"], "rxcui": ["260376", "313217"], "spl_set_id": ["521e4aad-c6ec-4410-867f-dd9ecc08d5b2"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (63629-5237-1)", "package_ndc": "63629-5237-1", "marketing_start_date": "20140213"}, {"sample": false, "description": "28 CAPSULE in 1 BOTTLE (63629-5237-2)", "package_ndc": "63629-5237-2", "marketing_start_date": "20140213"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (63629-5237-3)", "package_ndc": "63629-5237-3", "marketing_start_date": "20140213"}], "brand_name": "Terazosin", "product_id": "63629-5237_1b04f70e-e8d8-4005-82f5-53b9cf3c4e99", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "63629-5237", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041220", "listing_expiration_date": "20261231"}